Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2015, Article ID 316968, 10 pages
http://dx.doi.org/10.1155/2015/316968
Research Article

A Novel Approach of Targeted Immunotherapy against Adenocarcinoma Cells with Nanoparticles Modified by CD16 and MUC1 Aptamers

Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine of Peking Union Medical College, Beijing 100005, China

Received 14 April 2015; Accepted 4 June 2015

Academic Editor: Tae-Yub Kwon

Copyright © 2015 Lianyuan Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Vermes, H.-J. Guchelaar, and J. Dankert, “Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions,” Journal of Antimicrobial Chemotherapy, vol. 46, no. 2, pp. 171–179, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Reuther, T. Schuster, U. Mende, and A. C. Kübler, “Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients—a report of a thirty year retrospective review,” International Journal of Oral and Maxillofacial Surgery, vol. 32, no. 3, pp. 289–295, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. S. A. Rosenberg, “Progress in human tumour immunology and immunotherapy,” Nature, vol. 411, no. 6835, pp. 380–384, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Tarte and B. Klein, “Dendritic cell-based vaccine: a promising approach for cancer immunotherapy,” Leukemia, vol. 13, no. 5, pp. 653–663, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Kovjazin, I. Volovitz, Y. Kundel et al., “ImMucin: a novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors,” Vaccine, vol. 29, no. 29-30, pp. 4676–4686, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Berd, T. Sato, H. C. Maguire Jr., J. Kairys, and M. J. Mastrangelo, “Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine,” Journal of Clinical Oncology, vol. 22, no. 3, pp. 403–415, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. S. Yu, G. T. Liu, H. Ying, W. H. Yong, K. L. Black, and C. J. Wheeler, “Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma,” Cancer Research, vol. 64, no. 14, pp. 4973–4979, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Mesa and L. E. Fernández, “Challenges facing adjuvants for cancer immunotherapy,” Immunology and Cell Biology, vol. 82, no. 6, pp. 644–650, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Boltz, B. Piater, L. Toleikis, R. Guenther, H. Kolmar, and B. Hock, “Bi-specific aptamers mediating tumor cell lysis,” The Journal of Biological Chemistry, vol. 286, no. 24, pp. 21896–21905, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Hu, J. Duan, Q. Zhan, F. Wang, X. Lu, and X.-D. Yang, “Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitro,” PLoS ONE, vol. 7, no. 2, Article ID e31970, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Taylor-Papadimitriou, J. Burchell, D. W. Miles, and M. Dalziel, “MUC1 and cancer,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1455, no. 2-3, pp. 301–313, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Zhang, N. X. Zhao, Z. H. Zeng et al., “Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells,” Laboratory Investigation, vol. 89, no. 12, pp. 1423–1432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Chaturvedi, A. P. Singh, and S. K. Batra, “Structure, evolution, and biology of the MUC4 mucin,” The FASEB Journal, vol. 22, no. 4, pp. 966–981, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. E. A. Rakha, R. W. G. Boyce, D. A. El-Rehim et al., “Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer,” Modern Pathology, vol. 18, no. 10, pp. 1295–1304, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Ohuchida, K. Mizumoto, D. Yamada et al., “Quantitative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of pancreatic cancer,” International Journal of Cancer, vol. 118, no. 2, pp. 405–411, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. C. Chauhan, N. Vinayek, D. M. Maher et al., “Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: antigens for multi-targeted antibody-guided therapy,” Journal of Histochemistry & Cytochemistry, vol. 55, no. 8, pp. 867–875, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. O'Connor, J. Julian, S. D. Lim, and D. D. Carson, “MUC1 expression in human prostate cancer cell lines and primary tumors,” Prostate Cancer and Prostatic Diseases, vol. 8, no. 1, pp. 36–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. S. Kim, J. Gum Jr., and I. Brockhausen, “Mucin glycoproteins in neoplasia,” Glycoconjugate Journal, vol. 13, no. 5, pp. 693–707, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Sachdeva and Y.-Y. Mo, “MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1,” Cancer Research, vol. 70, no. 1, pp. 378–387, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Satoh, Y. Hinoda, T. Hayashi, M. D. Burdick, K. Imai, and M. A. Hollingsworth, “Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule,” International Journal of Cancer, vol. 88, no. 4, pp. 507–518, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Yu, Y. Hu, J. Duan et al., “Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro,” PLoS ONE, vol. 6, no. 9, Article ID e24077, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. C. S. M. Ferreira, M. C. Cheung, S. Missailidis, S. Bisland, and J. Gariépy, “Phototoxic aptamers selectively enter and kill epithelial cancer cells,” Nucleic Acids Research, vol. 37, no. 3, pp. 866–876, 2009. View at Publisher · View at Google Scholar · View at Scopus